First, despite bioinformatics analysis provided us a preliminary insight of the crucial role of RIPK2 in cancer progression and immunotherapy resistance, biological experiments in vitro and in vivo are still needed to validate our findings and promote clinical transformation. The gene discussed is RIPK2; the disease is cancer.